Comparison of the efficacy between topotecan- and belotecan-, a new camptothecin analog, based chemotherapies for recurrent epithelial ovarian cancer: a single institutional experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples